Vipul Gupta

Vipul Gupta is an accomplished professional in oncology drug development with extensive experience in pharmacokinetics and clinical pharmacology. Currently serving as Executive Director at Schrödinger since April 2023, Vipul previously held senior director roles at Arcus Biosciences and Spero Therapeutics, where responsibilities included overseeing drug development processes. Prior positions include Associate Director at Acceleron Pharma, Staff Scientist at Alkermes, and Senior Scientist I at Cubist Pharmaceuticals, where Vipul managed research teams and projects related to drug-drug interactions and pharmacokinetics. The foundation of Vipul's expertise was developed during tenure as Senior Research Investigator at Eisai and Research Investigator at Eisai Research Institute, alongside academic achievements, including a postdoctoral fellowship in pharmacokinetics from the University of Florida.